Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Dec;14(7-8):562-73.
doi: 10.3109/21678421.2013.794843. Epub 2013 May 16.

Myelin imaging in amyotrophic and primary lateral sclerosis

Affiliations
Free PMC article

Myelin imaging in amyotrophic and primary lateral sclerosis

Shannon Kolind et al. Amyotroph Lateral Scler Frontotemporal Degener. 2013 Dec.
Free PMC article

Abstract

Primary lateral sclerosis (PLS) has been regarded as a rare, extreme form of amyotrophic lateral sclerosis (ALS). Like ALS, it is a clinical diagnosis without established biomarkers. We sought to explore loss of cerebral myelin in relation to clinical features, including cognitive impairment, in cases of both ALS and PLS. A novel MRI sequence (mcDESPOT) sensitive to water pools within myelin and intra- and extra-cellular spaces was applied to 23 ALS patients, seven PLS patients and 12 healthy controls, with interval follow-up in 15 ALS and four PLS patients. Results demonstrated that PLS patients were distinguished by widespread cerebral myelin water fraction reductions, independent of disease duration and clinical upper motor neuron burden. ALS patients showed a significant increase in intra- and extra-cellular water, indirectly linked to neuroinflammatory activity. Limited measures of cognitive impairment in the ALS group were associated with myelin changes within the anterior corpus callosum and frontal lobe projections. Longitudinal changes were only significant in the PLS group. In conclusion, in this exploratory study, myelin imaging has potential to distinguish PLS from ALS, and may have value as a marker of extramotor involvement. PLS may be a more active cerebral pathological process than its rate of clinical deterioration suggests.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Reductions in MWF for PLS patients compared to healthy controls (A, significant reductions in orange with trends in blue), and PLS patients compared to ALS patients (B, significant reductions in red with trends in dark blue). Increases in IE-water T2 for PLS patients compared to healthy controls (C, non-significant trends in light blue) and ALS patients compared to healthy controls (D, significant increases in red-yellow with trends in green). All p-values corrected for multiple comparisons. Images displayed by radiological convention.
Figure 2.
Figure 2.
Regional white matter tract correlations, notably including the anterior corpus callosum and frontal projections, between lower ACE scores and reduced MWF in ALS patients (A), and increased IE-water T2 in ALS patients (B). All p-values corrected for multiple comparisons. Images displayed by radiological convention.
Figure 3.
Figure 3.
Regional white matter tract correlations, notably including anterior corpus callosum and frontal projections, between higher TMT B-A scores (reflecting dysexecutive function) and reduced MWF in the ALS group (A), in the ALS and PLS patients combined (B); IE-water T2 increases in ALS patients (C) and IE-water T2 increases in the combined group (D). All p-values corrected for multiple comparisons. Images displayed by radiological convention.
Figure 4.
Figure 4.
Regional white matter tract correlations, with a notable involvement of frontal lobe projections, between reduced category fluency and decreased MWF in ALS patients (A), decreased MWF in all patients (B), increased IE-water T2 in ALS patients only (C), and increased IE-water T2 in all patients (D). All p-values corrected for multiple comparisons. Images displayed by radiological convention.

Similar articles

Cited by

References

    1. Turner MR, Hardiman O, Benatar M, Brooks BR, Chio A, de Carvalho M, et al. Controversies and priorities in amyotrophic lateral sclerosis. Lancet Neurol. 2013;12:310–22. - PMC - PubMed
    1. Erb WH. Ueber einen wenig bekannen spinalen symptomencomplex. Berliner Klinische Wochenschrift. 1875;12:357–9.
    1. Stark FM, Moersch FP. Primary Lateral Sclerosis: A Distinct Clinical Entity. The Journal of Nervous and Mental Disease. 1945;102:332–7.
    1. Pringle CE, Hudson AJ, Munoz DG, Kiernan JA, Brown WF, Ebers GC. Primary lateral sclerosis: clinical features, neuropathology and diagnostic criteria. Brain. 1992;115:495–520. - PubMed
    1. Gordon PH, Cheng B, Katz IB, Pinto M, Hays AP, Mitsumoto H, et al. The natural history of primary lateral sclerosis. Neurology. 2006;66:647–53. - PubMed

Publication types